NCT04521764View on ClinicalTrials.gov

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

August 15, 2027

Study Completion Date

August 15, 2027

Conditions
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast AdenocarcinomaRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
Interventions
BIOLOGICAL

Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein

Given IT

PROCEDURE

Computed Tomography

Undergo CT scan

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Biopsy

Undergo tumor biopsy

PROCEDURE

Biospecimen Collection

Undergo blood and urine sample collection

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER